Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -166.66% is 243% below its 5-year average of -48.60%, near the low end of its 5-year range (-166.66%–42.97%).
As of the fiscal period ended Tuesday, June 30, 2026. 31.30% below its 12-month average of -126.93%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): -30.49%.
RETURN ON ASSETS (ROA)
-166.66%
RETURN ON ASSETS (ROA) AVG TTM
-126.93%
RETURN ON ASSETS (ROA) AVG 3Y
-59.31%
RETURN ON ASSETS (ROA) AVG 5Y
-48.60%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-31.30%
CURRENT VS 3Y AVG
-181.00%
CURRENT VS 5Y AVG
-242.93%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-416.94%
vs the sector median at left
Lite Strategy, Inc.
Market Cap
$47.81M
Return on Assets (ROA)
-166.66%
TTM Avg
-126.93%
3Y Avg
-59.31%
5Y Avg
-48.60%
Market Cap
$47.41M
Return on Assets (ROA)
-15.32%
TTM Avg
-31.60%
3Y Avg
-39.35%
5Y Avg
-32.49%
Market Cap
$47.47M
Return on Assets (ROA)
-71.66%
TTM Avg
-64.58%
3Y Avg
-65.51%
5Y Avg
-55.75%
Market Cap
$49.44M
Return on Assets (ROA)
-68.93%
TTM Avg
-45.51%
3Y Avg
-54.02%
5Y Avg
-50.43%
Market Cap
$49.44M
Return on Assets (ROA)
-22.27%
TTM Avg
-102.93%
3Y Avg
-118.23%
5Y Avg
-95.88%
Market Cap
$49.45M
Return on Assets (ROA)
-68.60%
TTM Avg
-124.17%
3Y Avg
-83.59%
5Y Avg
-65.75%
Market Cap
$49.47M
Return on Assets (ROA)
-11.23%
TTM Avg
-20.22%
3Y Avg
-14.66%
5Y Avg
-10.97%
Market Cap
$48.93M
Return on Assets (ROA)
-162.93%
TTM Avg
-287.06%
3Y Avg
-300.16%
5Y Avg
-220.25%
Market Cap
$49.55M
Return on Assets (ROA)
-37.53%
TTM Avg
-1.93%
3Y Avg
9.94%
5Y Avg
4.69%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lite Strategy, Inc. (LITS) | $47.81M | -166.66% | -126.93% | -59.31% | -48.60% |
| Instil Bio, Inc. (TIL)vs › | $47.41M | -15.32% | -31.60% | -39.35% | -32.49% |
| Celularity Inc. (CELU)vs › | $47.47M | -71.66% | -64.58% | -65.51% | -55.75% |
| TELA Bio, Inc. (TELA)vs › | $49.44M | -68.93% | -45.51% | -54.02% | -50.43% |
| Microbot Medical Inc. (MBOT)vs › | $49.44M | -22.27% | -102.93% | -118.23% | -95.88% |
| INmune Bio, Inc. (INMB)vs › | $49.45M | -68.60% | -124.17% | -83.59% | -65.75% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.47M | -11.23% | -20.22% | -14.66% | -10.97% |
| Apollomics, Inc. (APLM)vs › | $48.93M | -162.93% | -287.06% | -300.16% | -220.25% |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.55M | -37.53% | -1.93% | 9.94% | 4.69% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.21M | -143.30% | -71.59% | -49.53% | -40.25% |
ROA
-166.7%
ROE
-170.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | -166.66% |
| 2025-06-30 | -87.20% |
| 2024-06-30 | 42.97% |
| 2023-06-30 | -26.35% |
| 2022-06-30 | -30.62% |
| 2021-06-30 | -23.73% |
